DiFabio Andrea

CIK 00016925062 companiesBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001692506

Recent Transactions

35 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-01-09+15,000→ 15,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-01-09+80,000→ 80,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-03-12+80,000→ 80,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-03-12+15,000→ 15,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+100,000→ 100,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+45,000→ 45,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-11-07+135,000→ 135,000 total
Disposition to Issuer
Bioverativ Inc.
Common Stock
2018-03-08−30,600.203→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−59,595→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−29,797→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−29,797→ 0 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−31,818→ 0 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−7,489→ 0 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-23$104.74/sh−917→ 30,410.558 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-22$104.30/sh−2,011→ 31,327.558 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-14$103.52/sh−1,136→ 33,338.558 total
Exercise/Conversion
Bioverativ Inc.
Common Stock
2018-02-14+3,744→ 34,474.558 total
Exercise/Conversion
Bioverativ Inc.
Restricted Stock Units
2018-02-14−3,744→ 7,489 total
Award
Bioverativ Inc.
Restricted Stock Units
2018-01-31+31,818→ 31,818 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-11-02$53.65/sh−636→ 30,730.558 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$43.42/sh−718→ 30,818 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$47.76/sh−918→ 31,536 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$49.56/sh−368→ 34,462 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$49.56/sh−285→ 32,454 total
Award
Bioverativ Inc.
Common Stock
2017-02-28+35,019→ 35,985 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$43.42/sh−1,155→ 34,830 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$43.42/sh−532→ 32,739 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$47.76/sh−1,191→ 33,271 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+29,797→ 29,797 total
Award
Bioverativ Inc.
Restricted Stock Units
2017-02-14+11,233→ 11,233 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+29,744→ 29,744 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+29,744→ 29,744 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+29,797→ 29,797 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+59,595→ 59,595 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+59,488→ 59,488 total

Companies

Recent Filings

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov